Company: INDP
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001641172-25-006429
Chunk: 64

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 64
---
                        
 of (i) 1,341,524 shares of common stock held by the Michael J. Newman Trust, dated January      
 21, 2008, Michael J. Newman, Trustee; (ii) 26,832 shares of common stock held by Janet          
 Lee Harris, Trustee of the Janet Harris Living Trust, executed on March 25, 2009. Ms. Harris    
 is the spouse of Dr. Newman, and as such, Dr. Newman is deemed to beneficially own such shares; 
 and (iii) 383,808 shares of common stock issuable upon exercise of outstanding options, of      
 which 7,208 will vest within 60 days of days of April 17, 2025.                                 |

| (6) | Consists                                                                                            
 of (i) 202,859 shares of common stock, (ii) 127,485 shares of common stock issuable upon            
 exercise of warrants, and (ii) 691,667 shares of common stock issuable upon exercise of outstanding 
 options, of which 16,667 will vest within 60 days of days of April 17, 2025.                        |

| (7) | Consists                                                                                 
 of 83,750 shares of common stock issuable upon exercise of outstanding options, of which 
 13,750 will vest within 60 days of April 17, 2025.                                       |

| (8) | Consists                                                                                         
 of (i) 150 shares of common stock and (ii) 317,100 shares of common stock issuable upon exercise 
 of outstanding options, of which 9,583 will vest within 60 days of April 17, 2025.               |

| (9) | Consists                                                                                 
 of 52,500 shares of common stock issuable upon exercise of outstanding options, of which 
 12,500 will vest within 60 days of April 17, 2025.                                       |

| (10) | Consists                                                                                        
 of (i) 670 shares of common stock and (ii) 52,500 shares of common stock issuable upon exercise 
 of outstanding options, of which 12,500 will vest within 60 days of April 17, 2025.             |

| (11) | Consists                                                                                 
 of 52,500 shares of common stock issuable upon exercise of outstanding options, of which 
 12,500 will vest within 60 days of April 17,